Common Electrophysiology Biomarkers Collected at Home Robustly Track Depression Recovery With Deep Brain Stimulation
Preprint
Abstract
Subcallosal cingulate cortex (SCC) deep brain stimulation (DBS) can provide relief for individuals with Treatment Resistant Depression (TRD), but ongoing clinical management remains challenging due to nonspecific symptom fluctuations that can obscure core depression recovery on standard rating scales. Objective, stable biomarkers that selectively track the therapeutic effects of SCC DBS are therefore essential for developing principled decision support systems to guide stimulation adjustments. Recent bidirectional DBS systems enable chronic recording of local field potentials (LFPs) and prior work using the Activa PC+S device identified an electrophysiological signature of stable clinical recovery. However, translation to practical clinical deployment requires demonstrating that this biomarker is robustly generalizable, specific to the impact of the DBS therapy, and deployable in real-world recording contexts. To address this need, we developed an at-home SCC LFP data collection platform (built on the Medtronic Summit RC+S system) enabling at home data collection for a new cohort of ten SCC DBS participants with TRD (ClinicalTrials.gov identifier NCT04106466 ). Using longitudinal LFP recordings collected from this system, we report findings demonstrating that the previously reported biomarker of stable recovery generalizes across subject cohorts and devices, is robust to common potential confounds (including time of day and stimulation status), and shows symptom specificity, sensitivity and stability necessary to support clinical decision making. Across both cohorts, biomarker changes show relationships to pre-DBS white matter structure and network function measured using diffusion MRI and resting-state functional MRI (rsFMRI). These findings replicating and extending previous findings support the biomarker’s utility as a foundation for scalable, electrophysiology-informed decision support in SCC DBS.Keywords
Funding Information
- U.S. National Science Foundation (CCF-1350954)
- Wellcome Leap
This publication has 64 references indexed in Scilit:
- Long-Term Personalized Adaptive Deep Brain Stimulation in Parkinson DiseaseJAMA Neurology, 2025
- Revisiting subcallosal cingulate deep brain stimulation for depression: Long-term safety and effectiveness outcomes from a pooled analysis of 172 implanted patientsBrain Stimulation, 2025
- Deep brain stimulation induces white matter remodeling and functional changes to brain-wide networksBrain Stimulation, 2025
- Decoding Depression Severity From Intracranial Neural ActivityBiological Psychiatry, 2023
- The development of an implantable deep brain stimulation device with simultaneous chronic electrophysiological recording and stimulation in humansBiosensors and Bioelectronics, 2021
- Deep Brain Stimulation of the Ventral Anterior Limb of the Internal Capsule for Treatment-Resistant DepressionJAMA Psychiatry, 2016
- Defining Critical White Matter Pathways Mediating Successful Subcallosal Cingulate Deep Brain Stimulation for Treatment-Resistant DepressionBiological Psychiatry, 2014
- Development of a Computerized Adaptive Test for DepressionArchives of General Psychiatry, 2012
- Subcallosal Cingulate Deep Brain Stimulation for Treatment-Resistant Unipolar and Bipolar DepressionArchives of General Psychiatry, 2012
- Subcallosal Cingulate Gyrus Deep Brain Stimulation for Treatment-Resistant DepressionBiological Psychiatry, 2008